Cargando…
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets in Colorectal Cancer Patients
Blockade of inhibitory immune checkpoints (ICs) is a promising therapeutic approach; however, it has shown limited success in some cancers including colorectal cancer (CRC). The tumor microenvironment (TME) is largely responsible for response to therapy, and its constituents may provide robust bioma...
Autores principales: | Toor, Salman M., Murshed, Khaled, Al-Dhaheri, Mahmood, Khawar, Mahwish, Abu Nada, Mohamed, Elkord, Eyad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928042/ https://www.ncbi.nlm.nih.gov/pubmed/31921188 http://dx.doi.org/10.3389/fimmu.2019.02936 |
Ejemplares similares
-
Differential gene expression of tumor-infiltrating CD8(+) T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis
por: Saleh, Reem, et al.
Publicado: (2020) -
Correlations between Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets with Immune Checkpoints in Colorectal Cancer
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022) -
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
por: Saleh, Reem, et al.
Publicado: (2020) -
Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8(+) Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
por: Alsalman, Alhasan, et al.
Publicado: (2022) -
Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4(+) T Cells Associated with Poor Disease-Specific Survival
por: Toor, Salman M., et al.
Publicado: (2021)